scholarly journals Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications

2015 ◽  
pp. 4735 ◽  
Author(s):  
Hasniza Zaman Huri ◽  
Doris Ling Yew Hui ◽  
Wan Azman Wan Ahmad
2016 ◽  
Vol 52 (4) ◽  
pp. 801-812 ◽  
Author(s):  
Maria Aparecida Marczynski ◽  
Karine Laura Cortellazzi ◽  
Sílvio Barberato-Filho ◽  
Rogério Heládio Lopes Motta ◽  
Alexandre Eduardo Franzin Vieira ◽  
...  

2020 ◽  
Vol 22 (12) ◽  
pp. 57-62
Author(s):  
Irina I. Kochergina ◽  

The article presents data on the prevalence of diabetes and prediabetes; the high compatibility of diabetes mellitus and cardiovascular pathology; high mortality among patients with diabetes mellitus and coronary heart disease, in the presence of both acute and chronic cardiovascular complications; on the important role of glucose- and lipotoxicity in the progression of carbohydrate metabolism from prediabetes to type 2 diabetes mellitus, the role of hyperglycemia in the deve-lopment of insulin resistance, atherosclerosis, hypertension, liver, kidney, endothelial dysfunction, the role of hyper- and hypoglycemia in the development of acute vascular complications – myocardial infarction, stroke, gangrene of the lower extremities; on the protective role of adiponectin – a predictor of type 2 diabetes mellitus, on the importance of glycemic control for the timely detection of early disorders of carbohydrate metabolism – impaired glucose tolerance and impaired fasting glucose; on the role of metformin in the prevention of progression of prediabetes to type 2 diabetes and cardiac pathology; on the gluco- and cardioprotective role of modern sugar-lowering drugs.


Author(s):  
R. Aruthra ◽  
M. Ramkumar

Background: Type 2 Diabetes Mellitus (DM) is a disorder of the endocrine characterised by hyperglycaemia which results from variable degrees of insulin resistance and insulin deficiency.Chronic hyperglycaemia in diabetes may lead to multi organ damage resulting in renal, cardiovascular and other complications.In our study, we aim to look for correlation between the degree of glycemic control, duration of type 2 DM, incidence, severity of renal, cardiovascular complications in type 2 DM patients. The objective of our study is to analyse the correlation between glycemic control and occurrence of cardiovascular, renal complications in type 2 DM patients. Materials and Methods: 50 type 2 DM patients were selected from the Medicine outpatient of Saveetha Medical College and Hospital from January 2021 to March 2021.The study was explained and informed consent was obtained. Ethical committee clearance was obtained.The duration of the disease, regularity of treatment are recorded, serum HbA1c was done to evaluate the degree of glycemic control.Renal function tests like estimation of urea and creatinine are done to look for renal complications. Echocardiogram was done to evaluate the cardiac status of the patient. Expected Outcome: We expect a direct correlation between the severity of uncontrolled hyperglycaemia, duration of the disease with the incidence of renal and cardiovascular complications. Results: 50 patients who were selected for the study having type 2 Diabetes Mellitus, were made into two groups - people with uncontrolled diabetes (HbA1c >7.5%) were more prone in developing renal and cardiac complications which were assessed by urea, creatinine, urine protein levels and ejection fraction (EF %) values. The significant cut off values to cause complications were taken as for urea (>40mg/dl), creatinine (>1mg/dl), urine protein (+/++/+++), EF value(>50%) and the presence/absence of regional wall motion abnormality (RWMA) was noted. It was also observed that longer age duration of the disease, more was the risk to develop cardiac complications than disease of shorter duration. Hence a poor control of hyperglycaemia made the subject prone to renal and cardiovascular complications. Conclusion: We arrive at a direct correlation between the severity and extent of uncontrolled hyperglycaemia with the incidence of severity and complications in the form of nephropathy and cardiac dysfunction.


2022 ◽  
Vol 28 (5) ◽  
pp. 54-66
Author(s):  
O. M. Parkhomenko ◽  
B. M. Mankovsky ◽  
M. V. Vlasenko ◽  
L. K. Sokolova ◽  
Ya. M. Lutay ◽  
...  

The aim – to describe baseline data of the Ukraine cohort of DISCOVER Global Registry (DGR) with real-world insights on current treatment practices, complications, and associated clinical outcomes in people with type 2 diabetes mellitus (T2DM).Materials and methods. This healthcare provider-led prospective registry involves non‑interventional data collection from adults (aged ≥ 18 years) with T2DM receiving standard medical care as part of routine clinical practice per their treating physician’s discretion.Results and discussion. The initial data of 353 people with T2DM, who were included in the Ukrainian cohort of the DGR Register, were analyzed. The mean (±standard deviation) age of the study population was 58.85±10.02 years with female predominance (64 % [n=226]). The mean T2DM duration was 10.27±12.15 years with a mean glycated hemoglobin (HbA1c) level of 8.62±1.89 %. Only one-fifth (20.5 %, n=59) of the patients had glycemic control (HbA1c < 7.0 %). Among those with any complication, 73.8 % had microvascular and 79.3 % had cardiovascular complications. Retinopathy and heart failure were the most common microvascular and cardiovascular complications, respectively. Overall, 88 % of the patients were taking any antidiabetic therapy; of these, 27.3 % received insulin (monotherapy: n=28; combination therapy: n=57). As oral antidiabetic drugs (OAD), 32.2 % and 12.9 % received metformin and sulphonylurea monotherapies, respectively; minor proportions received newer OAD monotherapy (sodium-glucose co-transporter-2 inhibitors [4.8 %] and dipeptidyl peptidase-4 inhibitor [1 %]).Conclusions. Baseline data from the Ukraine cohort of DGR reveals poor glycemic control, with a higher mean HbA1c and proportion of patients with micro- and cardiovascular complications than that of the global cohort. The landscape of therapeutic agents displayed marked diversities in the management strategies. Robust real-world data from the DGR can help understand the gaps in care of T2DM patients and lights the need of the formulation of region-specific holistic therapeutic strategies to optimize glycemic control and improving clinical patients’ outcomes.


Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 137-LB ◽  
Author(s):  
NEHA KARAJGIKAR ◽  
KARLA B. DETOYA ◽  
JANICE N. BEATTIE ◽  
STACEY J. LUTZ-MCCAIN ◽  
MONIQUE Y. BOUDREAUX-KELLY ◽  
...  

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 90-LB
Author(s):  
SANJAY K. BAJPAI ◽  
RADHIKA NAIR ◽  
TICH CHANGAMIRE ◽  
RICHARD SHEER ◽  
QIANQIAN WANG ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document